Precision Biosensor, Inc. (KOSDAQ:335810)
1,732.00
-42.00 (-2.37%)
At close: Jun 5, 2026
Precision Biosensor Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7,874 | -10,023 | -7,305 | -4,490 | -6,806 | -4,152 |
Depreciation & Amortization | 3,919 | 3,957 | 3,590 | 3,145 | 2,282 | 1,179 |
Loss (Gain) From Sale of Assets | 64.51 | 16.05 | -3.01 | - | -5.27 | - |
Asset Writedown & Restructuring Costs | 1,981 | 1,981 | - | - | - | - |
Loss (Gain) From Sale of Investments | -9.02 | -2.42 | -33.36 | -90.06 | -137.79 | -48.66 |
Stock-Based Compensation | 130.36 | 116 | 46.61 | 155.26 | 150.33 | 73.59 |
Provision & Write-off of Bad Debts | 18.99 | 36.98 | -103.57 | 241.11 | 164.95 | 1.51 |
Other Operating Activities | 2,592 | 3,383 | 2,624 | 679.14 | 3,305 | 527.58 |
Change in Accounts Receivable | -1,249 | -346.66 | 403.1 | -342.54 | 554.94 | 1,461 |
Change in Inventory | 334.64 | 15.86 | 436.79 | 108.1 | -1,940 | -2,421 |
Change in Accounts Payable | 510.25 | 254.72 | -34.56 | -385.38 | -276.4 | -947.73 |
Change in Other Net Operating Assets | -1,230 | -901.8 | -1,064 | -973.59 | 132.85 | -246.8 |
Operating Cash Flow | -811.58 | -1,513 | -1,444 | -1,953 | -2,576 | -4,575 |
Capital Expenditures | -183.76 | -157.43 | -64.96 | -7,053 | -11,142 | -9,151 |
Sale (Purchase) of Intangibles | -4.9 | - | - | - | -3,785 | -25.8 |
Investment in Securities | -5,827 | -5,000 | 5,534 | -2,907 | 16,139 | -19,956 |
Other Investing Activities | 40.94 | 17.7 | 107.77 | 28.64 | -378.78 | -45.25 |
Investing Cash Flow | -4,229 | -4,893 | 5,576 | -9,931 | 142.17 | -29,178 |
Short-Term Debt Issued | - | - | - | - | - | 285.08 |
Long-Term Debt Issued | - | - | 2,994 | 14,976 | 3,600 | 16,882 |
Total Debt Issued | - | - | 2,994 | 14,976 | 3,600 | 17,167 |
Long-Term Debt Repaid | - | -8,983 | -8,006 | -8,391 | -633.61 | -357.1 |
Total Debt Repaid | -9,834 | -8,983 | -8,006 | -8,391 | -633.61 | -357.1 |
Net Debt Issued (Repaid) | -9,834 | -8,983 | -5,012 | 6,585 | 2,966 | 16,810 |
Issuance of Common Stock | 16,979 | 16,979 | - | 136.2 | 1,243 | 635.31 |
Other Financing Activities | 7.37 | 22 | - | -0 | -0 | -0 |
Financing Cash Flow | 6,943 | 8,018 | -5,012 | 6,721 | 4,209 | 17,445 |
Foreign Exchange Rate Adjustments | 71.79 | -44.72 | 175.84 | 32.37 | 237.64 | -53.02 |
Net Cash Flow | 1,974 | 1,568 | -703.55 | -5,130 | 2,013 | -16,361 |
Free Cash Flow | -995.33 | -1,670 | -1,509 | -9,006 | -13,719 | -13,726 |
Free Cash Flow Margin | -4.46% | -8.38% | -7.89% | -44.17% | -67.06% | -86.40% |
Free Cash Flow Per Share | -68.74 | -132.32 | -129.93 | -776.13 | -1190.18 | -1215.81 |
Cash Interest Paid | 478.29 | 483.68 | 518.27 | 428.63 | 154.35 | 17.46 |
Cash Income Tax Paid | 9.84 | 42.08 | 17.43 | -78.94 | 55.85 | -19.45 |
Levered Free Cash Flow | -3,904 | -2,139 | -11.76 | -10,697 | -11,321 | -14,441 |
Unlevered Free Cash Flow | -2,708 | -827.96 | 1,232 | -9,928 | -10,811 | -14,340 |
Change in Working Capital | -1,635 | -977.88 | -258.87 | -1,593 | -1,529 | -2,155 |